RIA

FNY Investment Advisers, LLC

New York, NY SEC Registered Investment Advisor and institutional investment manager affiliated with the First New York trading platform, filing under CIK #0001742998 Institutional CIK: 0001742998
13F Score ?
7
3-Year
13F Score ?
5
7-Year
S&P 500 ?
80
Benchmark
$354M
AUM
+2.76%
2025 Q4
+18.10%
1-Year Return
+31.72%
Top 10 Concentration
+53.09%
Turnover
+13.89%
AUM Change
Since 2018
First Filing
1207
# of Holdings

Fund Overview

About
Investment Strategy
Analytics Summary
Risk Profile

Activity Summary — 2025 Q4

Q4 2025 13F Filed: Jan 16, 2026

Top Buys

% $
Stock % Impact
CDTX CIDARA THERAPEU.. +9.07%
BMO BANK OF MONTREA.. +3.82%
SILJ AMPLIFY JUNIOR .. +3.01%
COPX GLOBAL X COPPER.. +2.72%
MPWR MONOLITHIC POWE.. +2.69%
MS MORGAN STANLEY .. +1.88%

Top Sells

% $
Stock % Impact
VRNA VERONA PHARMA A.. Sold All 😨 Was: 5.08% -4.46%
SBSW SIBANYE STILLWA.. -1.10%
MSFT MICROSOFT ORD..
CALL Option
-1.10%
TLT ISHARES 20 PLS .. -0.96%
SGML SIGMA LITHIUM O.. -0.72%
VTI VANGUARD TOTAL .. Sold All 😨 Was: 0.79% -0.69%

Top Holdings

2025 Q4
Stock %
CDTX Cidara Thera.. 9.07%
BMO Bank Of Mont.. 3.82%
UNH Unitedhealth.. 3.02%
SILJ Amplify Juni..
ETF
3.01%
COPX Global X Cop..
ETF
2.72%
MPWR Monolithic P.. 2.69%
View All Holdings

Activity Summary

Latest
Market Value $354M
AUM Change +13.89%
New Positions 297
Increased Positions 188
Closed Positions 556
Top 10 Concentration +31.72%
Portfolio Turnover +53.09%
Alt Turnover +59.20%

Sector Allocation Trends

Quarterly History
Free View: Last 10 Quarters. Subscribe to see full history

Holdings Analysis

Size: % of Portfolio Color: Last Full-Quarter Return No data
Free: 10 quarters

Positions Dynamics

Visualizing Top 20 holdings weight history over the last 10 quarters.

Portfolio Analytics — Latest

FNY Investment Advisers, LLC risk dashboard covering volatility, beta, value-at-risk, drawdowns, concentration, factor tilts, benchmark comparison, and stress testing for the latest disclosed portfolio.

Risk access
Building institutional risk profile...
Guru Intelligence Hub Pro
Real-time Analytics
High-Conviction Alpha
AAPL 92.4
NVDA 88.1
MSFT 74.3
Strategy Guardian
Style Drift 0.12
Sector Rotation 0.38

Tracking institutional benchmark deviation

Scenario Lab
2008 GFC -32.4%
Covid-19 -18.1%
2022 Bear -24.7%
Unlock the full Guru Intelligence Hub
Real conviction scores for every holding  ·  Strategy Guardian alerts  ·  Live Scenario Lab stress tests
Upgrade to Pro

Best Strategy vs. Benchmarks

AI Backtest: Auto-Optimizing...
Loading AI Backtest...
Don't be Fooled by Randomness
Access Alpha, Capture Ratios, and Batting Average calibrated for this specific strategy.
UPGRADE NOW
NT
Returns
--
Latest Quarter
--
1-Year Return
--
Ann. Return
Risk
--
Std Deviation
--
Max Drawdown
--
Beta vs SPY
Quality
--
Sharpe
--
Sortino
--
Win Rate
Edge Metrics Last 10 quarters only
--
Alpha annualized
--
Up Capture
--
Down Capture

Strategy Backtester: FNY Investment Advisers, LLC

Replicate top holdings performance • Compare vs benchmarks • Optimize N

Find the best N! Test multiple portfolio sizes at once to discover the optimal configuration.

Risk insights! Identify periods when the fund lagged the benchmark – critical for timing entries.

⏱ Run Backtest

Liquid Glass Edition

0
Backtests Run
+127%
Avg. Return

👆 Click the button to launch tickers!

Don't Be Fooled by Randomness
Proven alpha spans cycles, not just 24 months. Unlock full history since 1999.
PRO ACCESS
Free Demo
Try the Backtester on Real Funds
Run full-history backtests on a curated 2-3 funds. See signal quality, drawdowns, and cycle behavior before you decide.
Underperformance Analysis — Top 10 Holdings vs SPY

Backtesting FNY Investment Advisers, LLC's top 10 holdings against SPY identified 20 underperformance periods. Worst drawdown: 2023-01 – 2023-10 (-43.5% vs SPY, 10 quarters).

Avg. lag: -12.4% vs SPY Avg. duration: 2.9 quarters
Backtest Snapshot — Top 10 Holdings (Mn-Weighted)

The ticker-level breakdown shows how each of FNY Investment Advisers, LLC's top holdings contributed to portfolio returns quarter by quarter. Strongest recent contributors inside the last 5 years of the quarterly Top 10 backtest window: BN (2024 Q2 – 2024 Q2, +10.9 pts), CHRD (2022 Q2 – 2022 Q2, +7.9 pts), AMZN (2021 Q1 – 2025 Q1, +6.4 pts), NVDA (2023 Q3 – 2025 Q3, +5.9 pts), HLN (2022 Q3 – 2022 Q3, +5.9 pts) .

Strategy ann.: 4.8% SPY ann.: 14.8% Period: 2018–2026
Best Recent Contributors — Last 5Y
All 5 recent top contributors beat SPY, which means this fund's strongest recent return drivers also outperformed the index over the same window.
2024 Q2 – 2024 Q2 • 1Q in Top 10 Beat SPY
BN
+29%
SPY
+13%
Contrib
+10.9%
2022 Q2 – 2022 Q2 • 1Q in Top 10 Beat SPY
CHRD
+46%
SPY
+-3%
Contrib
+7.9%
2021 Q1 – 2025 Q1 • 3Q in Top 10 Beat SPY
AMZN
+58%
SPY
+35%
Contrib
+6.4%
2023 Q3 – 2025 Q3 • 6Q in Top 10 Beat SPY
NVDA
+74%
SPY
+20%
Contrib
+5.9%
2022 Q3 – 2022 Q3 • 1Q in Top 10 Beat SPY
HLN
+30%
SPY
+6%
Contrib
+5.9%
Stock return (green = beat SPY)   Stock return (red = lagged SPY)   SPY same period   Cumulative contribution during the last 5 years of the quarterly Mn-weighted Top 10 strategy

Disclaimer: 13Foresight is not a registered investment adviser, broker-dealer, or financial planner. All information on this site is provided solely for informational and educational purposes and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Portfolio backtests shown on this page are hypothetical and simulated — they do not represent actual trading results and were constructed with the benefit of hindsight. Actual results would differ materially. 13F filings disclose only long equity positions valued above $10,000, submitted up to 45 days after quarter-end; they do not capture short positions, options, bonds, cash, private investments, or non-U.S. securities. A fund's backtest performance may not reflect its actual returns, as managers frequently generate alpha through strategies not visible in 13F data. Past performance is not indicative of future results. All data sourced from public SEC EDGAR filings. Use at your own risk. Full Terms of Use.